Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Short Interest Update

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 15,900 shares, an increase of 106.5% from the March 15th total of 7,700 shares. Based on an average daily trading volume, of 56,600 shares, the days-to-cover ratio is presently 0.3 days.

Reviva Pharmaceuticals Price Performance

Shares of NASDAQ:RVPHW traded down $0.00 during midday trading on Wednesday, hitting $0.04. 17,190 shares of the stock were exchanged, compared to its average volume of 31,462. The business’s fifty day simple moving average is $0.09 and its two-hundred day simple moving average is $0.15. Reviva Pharmaceuticals has a 52-week low of $0.02 and a 52-week high of $0.78.

About Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.